udeceased

[andrewdudum @AndrewDudum]

@dranantmd is the clinical voice this conversation needs. Glad to have him sharing real-world experiences at the FDA this week.

[Alps @alpaysh]

BREAKING: Elon Musk hires Nicki Minaj as Chief Gyatt Officer at SpaceX

[Cryptex Finance @CryptexFinance]

Probably the best clips from the UFO files.

Disclosure is coming 🛸

[FBI Director Kash Patel @FBIDirectorKash]

President Trump’s law enforcement team led by this FBI is conducting the most aggressive violent crimes against children takedowns in United States history - and we’re not slowing down.

[Elon Musk @elonmusk]

It was an honor to be shown the awesome @Intel fab in Oregon this week. Looking forward to a great partnership with @SpaceX & @Tesla!

[Palm Beach Pete @not_jeffepstein]

I’m the CEO

[AI Edge @aiedge_]

Elon Musk after removing Anthropic's biggest bottleneck while simultaneously killing their #1 competitor (OpenAI).

[Elon Musk @elonmusk]

https://t.co/LH6vwKppAi

[Hims House @himshouse]

LINK TO INTERVIEW:

https://t.co/jZhlLrUK73

[andrewdudum @AndrewDudum]

As of this morning, providers on our platform can now send prescriptions for Zepbound® vials and KwikPen®, as well as Foundayo™, to the LillyDirect® pharmacy and access self-pay pricing for our customers because of an expansion in our platform’s functionality.

In many ways, today reminds me of Netflix’s early days, when everyone talked about whether they would have the latest blockbuster in their catalog. As if Netflix’s success depended on its ability to become the distribution channel for a single film.

They were missing the forest for the trees: Netflix wasn’t just renting DVDs. It was changing consumer behavior by ruthlessly prioritizing choice and inventing new pathways to the things people wanted the most.

By offering a full range of FDA-approved GLP-1s on our platform, we’re similarly giving our customers more choices through all the tools we have available – and we’ll continue to push here on behalf of everyone who depends on us for their care.

Read more on how we’re making this possible, including important info, here:

https://t.co/HxYN1KhGwS

[udeceased @udeceased]

@himshouse

[Antonio Linares @alc2022]

No one wanted $Hims at $15

Now everyone wants it at $30

The whole planet will be chasing it at $500

[Cryptex Finance @CryptexFinance]

DeFi overcomplicated staking.

We didn’t.

Single Sided Staking is now live.

• Earn rewards (veCTX)
• Vote
• Run governance

No pairs. No nonsense. Just CTX.

Powered by @AragonProject

[Novo Nordisk @novonordisk]

Novo Nordisk and @OpenAI partner to transform how medicines are discovered and delivered. Read more here:
https://t.co/JJoSqHmOzA

[Kalshi @Kalshi]

JUST IN: Iran to reportedly require ships passing through Strait of Hormuz to pay tolls in Bitcoin

[andrewdudum @AndrewDudum]

I love days like today because it’s when we get to show how efficiently we can help our customers connect with a provider, find the treatment that is right for them, and get it in their hands.

Our first @novonordisk product shipments are heading to homes now! Big thanks to our talented team in Arizona who got the first one out the door this afternoon.

[Andrew Tate @Cobratate]

ALL YOUR INVESTMENTS WILL FAIL

[andrewdudum @AndrewDudum]

We founded Hims & Hers to help more people feel great. To disrupt a broken healthcare system and create a new model of health where innovators work together to deliver access to care that actually serves everyday people.

We align how we operate with where we see major growth opportunities and in a way that allows us to meet our customers where they are (and where they want to go). That’s why, later this month, Hims & Hers customers will have access to FDA-approved medications from @novonordisk as a part of a strategic collaboration.

The weight loss landscape is completely different today than it was when we first entered the category. FDA-approved GLP-1 treatments are now more accessible, with greater affordability and more flexible dosing options and form factors. These market changes are shifting consumer demand towards these branded medications.

We’re moving our model forward another step with this strategic shift in our US weight loss business. This evolution will make us the largest global consumer health platform providing access to more affordable, approved medications.

We will continue to innovate across our platform, keeping what’s best for consumers as our North Star. There's challenging, important work in front of us, and I've never been more excited about the path ahead. Just like we always do, Hims & Hers will rise to meet the moment.

More here: https://t.co/jcWkrvvkts

Important info here: https://t.co/WiCHFnUnN2